Pulmonary Rehabilitation Frequency in COPD Patients
Comparative Efficacy of a Supervised Pulmonary Rehabilitation Program Performed 3 Days/Week Versus 1 Day/Week in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial
1 other identifier
interventional
158
0 countries
N/A
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common condition that can cause breathlessness and reduced physical capacity. Pulmonary rehabilitation (PR) is an effective treatment, but traditional programs often require patients to attend sessions several times per week, which may limit participation. This study aims to compare the effectiveness of two supervised pulmonary rehabilitation programs: one performed 3 days per week and another performed 1 day per week, both over an 8-week period and including additional home-based exercises. The main objective is to determine whether the lower-frequency program is not inferior to the higher-frequency program in improving functional capacity, measured by the six-minute walk test. Secondary outcomes include dyspnea, quality of life, muscle strength, physical activity, adherence, exacerbations, and safety. The results of this study may help optimize pulmonary rehabilitation programs and improve accessibility for patients with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2027
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
Study Completion
Last participant's last visit for all outcomes
August 1, 2028
May 8, 2026
May 1, 2026
1 year
May 4, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional capacity assessed by the six-minute walk test (6MWT)
Functional capacity will be measured using the six-minute walk test (6MWT), expressed as distance walked in meters.
Change from baseline to 8 weeks (end of intervention)
Secondary Outcomes (14)
Maximal inspiratory pressure (MIP)
Change from baseline to 8, 12, and 24 weeks
Maximal expiratory pressure (MEP)
Change from baseline to 8, 12, and 24 weeks
Quadriceps muscle strength
Change from baseline to 8, 12, and 24 weeks
Five-times sit-to-stand test (5STS)
Change from baseline to 8, 12, and 24 weeks
One-minute sit-to-stand test (1-min STS)
Change from baseline to 8, 12, and 24 weeks
- +9 more secondary outcomes
Study Arms (2)
Pulmonary Rehabilitation 3 Days/Week
EXPERIMENTALParticipants receive supervised pulmonary rehabilitation three times per week for 8 weeks, including exercise training and educational components, complemented by a home-based program.
Pulmonary Rehabilitation 1 Day/Week
EXPERIMENTALParticipants receive supervised pulmonary rehabilitation once per week for 8 weeks, including exercise training and educational components, complemented by a home-based program.
Interventions
Supervised pulmonary rehabilitation program including exercise training and educational components, complemented by a home-based program.
Eligibility Criteria
You may qualify if:
- Diagnosis of COPD confirmed by spirometry (FEV₁/FVC \<0.70)
- Modified Medical Research Council (mMRC) dyspnoea scale ≥2
- Ability to actively participate and perform physical exercise
- Signed informed consent
You may not qualify if:
- Unstable cardiac or musculoskeletal comorbidity contraindicating or limiting exercise
- Moderate to severe cognitive impairment or inability to understand instructions
- Recent participation (\<6 months) in a complete pulmonary rehabilitation programme
- Inability to attend the centre 1-3 days/week according to group allocation
- Current participation in any structured pulmonary rehabilitation programme or supervised rehabilitation intervention in another centre.
- Active oncological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (30)
Junta de Andalucía. Cuestionario de actividad física IPAQ [Internet]. [citado 2026 May 4]. Disponible en: https://www.juntadeandalucia.es/export/drupaljda/salud_5af95872aeaa7_cuestionario_actividad_fisica_ipaq.pdf
RESULTArmijo S, Behrens C, Giaconi Smoje ME, Hurtado Mura A, Fernández MR, Parra Ponce P, et al. Validación de la versión en español de un instrumento de evaluación de la comunicación centrada en el paciente en OSCE. Educación médica [Internet]. 2021 [citado 4 de mayo de 2026];22(4):193-8. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8015048
RESULTNikolovski A, Gamgoum L, Deol A, Quilichini S, Kazemir E, Rhodenizer J, Oliveira A, Brooks D, Alsubheen S. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in individuals with stable chronic obstructive pulmonary disease (COPD): a systematic review. Disabil Rehabil. 2024 Apr;46(7):1230-1238. doi: 10.1080/09638288.2023.2182918. Epub 2023 Mar 2.
PMID: 36861817RESULTBenzo R, Flume PA, Turner D, Tempest M. Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil. 2000 Jul-Aug;20(4):231-4. doi: 10.1097/00008483-200007000-00003.
PMID: 10955263RESULTBestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.
PMID: 10377201RESULTGephine S, Bergeron S, Tremblay Labrecque PF, Mucci P, Saey D, Maltais F. Cardiorespiratory Response during the 1-min Sit-to-Stand Test in Chronic Obstructive Pulmonary Disease. Med Sci Sports Exerc. 2020 Jul;52(7):1441-1448. doi: 10.1249/MSS.0000000000002276.
PMID: 31977637RESULTFarley C, Newman ANL, Phillips SM, Smith-Turchyn J, Brooks D. Measurement properties of the sit-to-stand test in community-dwelling people with chronic obstructive pulmonary disease: a COSMIN systematic review. Thorax. 2025 Dec 12:thorax-2025-223967. doi: 10.1136/thorax-2025-223967. Online ahead of print.
PMID: 41386962RESULTSentanin AC, de Facio CA, da Silva MMC, Sousa FC, Arcuri JF, Mendes RG, Di Lorenzo VAP. Reliability of Quadriceps Femoris Muscle Strength Assessment Using a Portable Dynamometer and Protocol Tolerance in Patients With Chronic Obstructive Pulmonary Disease. Phys Ther. 2021 Sep 1;101(9):pzab107. doi: 10.1093/ptj/pzab107.
PMID: 33792725RESULTJenkins TO, Edwards GD, Patel S, Canavan J, Kon SSC, Barker RE, Jones SE, Walsh JA, Ingram KA, Maddocks M, Polkey MI, Nolan CM, Man W. Minimal important difference of quadriceps maximal voluntary contraction (QMVC) in COPD: a prospective cohort study. Thorax. 2026 Jan 27:thorax-2025-223799. doi: 10.1136/thorax-2025-223799. Online ahead of print.
PMID: 41593004RESULTXie J, Zhu Y, Wang Y, Mo Y, Shi X, Liang WM, Ren FF, Bai Z, Nie F. Effects of pulmonary rehabilitation combined with inspiratory muscle training on lung function and exercise capacity in older patients with COPD: a systematic review and meta-analysis. Front Med (Lausanne). 2025 Jul 9;12:1621375. doi: 10.3389/fmed.2025.1621375. eCollection 2025.
PMID: 40703265RESULTLista-Paz A, Langer D, Barral-Fernandez M, Quintela-Del-Rio A, Gimeno-Santos E, Arbillaga-Etxarri A, Torres-Castro R, Vilaro Casamitjana J, Varas de la Fuente AB, Serrano Veguillas C, Bravo Cortes P, Martin Cortijo C, Garcia Delgado E, Herrero-Cortina B, Valera JL, Fregonezi GAF, Gonzalez Montanez C, Martin-Valero R, Francin-Gallego M, Sanesteban Hermida Y, Gimenez Moolhuyzen E, Alvarez Rivas J, Rios-Cortes AT, Souto-Camba S, Gonzalez-Doniz L. Maximal Respiratory Pressure Reference Equations in Healthy Adults and Cut-off Points for Defining Respiratory Muscle Weakness. Arch Bronconeumol. 2023 Dec;59(12):813-820. doi: 10.1016/j.arbres.2023.08.016. Epub 2023 Sep 29. English, Spanish.
PMID: 37839949RESULTHolland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010 Feb;91(2):221-5. doi: 10.1016/j.apmr.2009.10.017.
PMID: 20159125RESULTGimeno-Santos E, Vilaro J, Arbilllaga-Etxarri A, Herrero-Cortina B, Ramon MA, Corbero AB, Fernandez-Dominguez JC, Zarate-Tejero C, Barberan-Garcia A, Del Corral T, Jimenez-Reguera B, Lopez A, Lopez-Fernandez D, Treves PM, Martinez-Alejos R, Munoz G, Rios-Cortes A, Ruiz-Lopez K, San Miguel-Pagola M, Sanchez-Cayado N, Valeiro B, Valenza MC, Valenza G, Varas AB, Cordoba S, Vega A, Linares M, Madrid EM, Souto S, Vendrell M, Garcia-Aymerich J. Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 Years. Arch Bronconeumol. 2025 Aug;61(8):459-466. doi: 10.1016/j.arbres.2025.01.005. Epub 2025 Jan 17. English, Spanish.
PMID: 39890527RESULTNielsen C, Godtfredsen N, Molsted S, Ulrik C, Kallemose T, Hansen H. Supervised pulmonary tele-rehabilitation and individualized home-based pulmonary rehabilitation for patients with COPD, unable to participate in center-based programs. The protocol for a multicenter randomized controlled trial - the REPORT study. PLoS One. 2025 Jan 7;20(1):e0312742. doi: 10.1371/journal.pone.0312742. eCollection 2025.
PMID: 39774509RESULTXin H, Wei S, Zheng H, Qi Y, Xu S, Wang B, Jiang W, Deng N, Chen J. Comparison of a Supervised Home-Based Tele-Rehabilitation with Center-Based Pulmonary Rehabilitation: Protocol for a Randomized Non-Inferiority Multicenter Study in Ningxia. Int J Chron Obstruct Pulmon Dis. 2024 Jul 25;19:1707-1719. doi: 10.2147/COPD.S467945. eCollection 2024.
PMID: 39081777RESULTCox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.
PMID: 33511633RESULTNolan CM, Glen C, Walsh JA, Patel S, Barker RE, Polgar O, Spain N, Littlemore H, Jung P, Edwards GD, Jenkins TO, Harvey J, Ingram K, Newby C, Steiner M, Wilson R, Gao W, Fiorentino F, Chukwusa E, May P, Maddocks M, Man WDC. Minimal vs Specialized Exercise Equipment for Pulmonary Rehabilitation: A Randomized Clinical Trial. JAMA Netw Open. 2025 Aug 1;8(8):e2526616. doi: 10.1001/jamanetworkopen.2025.26616.
PMID: 40794408RESULTCieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021 Dec 19;396(10267):2006-2017. doi: 10.1016/S0140-6736(20)32340-0. Epub 2020 Dec 1.
PMID: 33275908RESULTPandya K, Davis AM, Anderson MR. Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease. JAMA. 2025 Mar 4;333(9):804-805. doi: 10.1001/jama.2024.24883.
PMID: 39908028RESULTMcCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. doi: 10.1002/14651858.CD003793.pub3.
PMID: 25705944RESULTBurge AT, Cox NS, Abramson MJ, Holland AE. Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2020 Apr 16;4(4):CD012626. doi: 10.1002/14651858.CD012626.pub2.
PMID: 32297320RESULTPuhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016 Dec 8;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4.
PMID: 27930803RESULTRochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, Spruit MA, Masefield S, Casaburi R, Clini EM, Crouch R, Garcia-Aymerich J, Garvey C, Goldstein RS, Hill K, Morgan M, Nici L, Pitta F, Ries AL, Singh SJ, Troosters T, Wijkstra PJ, Yawn BP, ZuWallack RL; ATS/ERS Task Force on Policy in Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86. doi: 10.1164/rccm.201510-1966ST.
PMID: 26623686RESULTBull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.
PMID: 33239350RESULTCheng SWM, Alison JA, Stamatakis E, Dennis SM, McKeough ZJ. Patterns and Correlates of Sedentary Behaviour Accumulation and Physical Activity in People with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. COPD. 2020 Apr;17(2):156-164. doi: 10.1080/15412555.2020.1740189. Epub 2020 Mar 26.
PMID: 32216475RESULTLopmeri M, Mattila T, Tokola K, Vasankari T, Jaaskelainen T, Lahti J, Vasankari T. Association of impaired pulmonary function and objectively measured physical activity in a population study. Sci Rep. 2025 Jul 24;15(1):27004. doi: 10.1038/s41598-025-12517-2.
PMID: 40707715RESULTCosio BG, Hernandez C, Chiner E, Gimeno-Santos E, Pleguezuelos E, Seijas N, Rigau D, Lopez-Campos JL, Soler-Cataluna JJ, Calle M, Miravitlles M, Casanova C; en nombre del equipo de trabajo de GesEPOC 2021. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update. Arch Bronconeumol. 2022 Apr;58(4):345-351. doi: 10.1016/j.arbres.2021.08.010. Epub 2021 Sep 17. English, Spanish.
PMID: 35312554RESULTWard TJC, Latimer L, Daynes E, Freeman SC, Ward S, Xu J, Haris M, Bakali M, Reap S, Iqbal M, Wang L, Mavilakandy A, Olaiya A, Aung H, Harvey-Dunstan TC, Singh SJ, Greening NJ, Evans RA, Steiner MC, Sutton AJ. Impact of pulmonary rehabilitation programme design on effectiveness in COPD: a systematic review and component network meta-analysis. EClinicalMedicine. 2025 Aug 20;87:103433. doi: 10.1016/j.eclinm.2025.103433. eCollection 2025 Sep.
PMID: 40896469RESULTAlison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, McDonald VM, Frith P, Cafarella P, Brooke M, Cameron-Tucker HL, Candy S, Cecins N, Chan AS, Dale MT, Dowman LM, Granger C, Halloran S, Jung P, Lee AL, Leung R, Matulick T, Osadnik C, Roberts M, Walsh J, Wootton S, Holland AE; Lung Foundation Australia and the Thoracic Society of Australia and New Zealand. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017 May;22(4):800-819. doi: 10.1111/resp.13025. Epub 2017 Mar 24.
PMID: 28339144RESULTVenkatesan P. GOLD COPD report: 2025 update. Lancet Respir Med. 2025 Jan;13(1):e7-e8. doi: 10.1016/S2213-2600(24)00413-2. Epub 2024 Dec 5. No abstract available.
PMID: 39647487RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, participants and care providers cannot be blinded. Outcome assessors are blinded to group allocation. Baseline and post-intervention evaluations are conducted by different assessors. Personnel performing functional tests, muscle strength assessments, and administering clinical scales remain unaware of treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, Department of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
May 4, 2026
First Posted
May 8, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
May 8, 2026
Record last verified: 2026-05